載入中
NASDAQHealthcareMedical - Devices
最新資料
US$60.81
−US$0.86 · -1.39%
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
一般交易時段
US$60.81
−US$0.86 · -1.39%
盤中時間採用ET。市場資料可能有所延遲。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日內區間
目前US$60.81
52週區間
目前US$60.81
盤中時間採用ET。市場資料可能有所延遲。
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
日內區間
目前US$60.81
52週區間
目前US$60.81
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 2.11億 USD | 1.66億 USD | 1.65億 USD | 1.62億 USD | 1.27億 USD |
| 銷貨成本 | 6476.8萬 USD | 5650萬 USD | 5817.4萬 USD | 5510.5萬 USD | 4127.8萬 USD |
| 毛利 | 1.46億 USD | 1.1億 USD | 1.07億 USD | 1.07億 USD | 8540.4萬 USD |
| 研究與開發 | 2024.7萬 USD | 1970.6萬 USD | 2642.8萬 USD | 2026.9萬 USD | 1831.5萬 USD |
| 銷售、一般及管理費用 | 1.65億 USD | 1.4億 USD | 1.46億 USD | 1.26億 USD | 9222.9萬 USD |
| 營業費用 | 1.85億 USD | 1.6億 USD | 1.72億 USD | 1.46億 USD | 1.11億 USD |
| 利息收入 | 42.3萬 USD | 147.7萬 USD | 102萬 USD | 8.7萬 USD | 2.3萬 USD |
| 利息支出 | 2525.6萬 USD | 2082.9萬 USD | 1539.3萬 USD | 1176萬 USD | 906.2萬 USD |
| 折舊和攤銷 | 1047.4萬 USD | 757.7萬 USD | 488.3萬 USD | 433.9萬 USD | 412.4萬 USD |
| 營業利益 | −3900.8萬 USD | −4998.7萬 USD | −6502.6萬 USD | −3965.8萬 USD | −2514萬 USD |
| 淨利 | −5106.4萬 USD | −8459.6萬 USD | −7850.2萬 USD | −7520.9萬 USD | −4113.9萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$102
上漲空間 67.74%報告持有此股票曝險的交易所交易基金。
iShares Russell 2000 ETFIWM4361.42萬0.06%787.4億 USD0.19%US$278.12-0.29%
iShares Russell 2000 Growth ETFIWO1541.45萬0.11%139.17億 USD0.24%US$354.69-0.59%
Vanguard Russell 2000 ETFVTWO1080.03萬0.06%180億 USD0.06%US$112.35-0.28%
T. Rowe Price Small-Mid Cap ETFTMSL537.79萬0.18%30.87億 USD0.55%US$41.09-0.22%
Vanguard Health Care ETFVHT391.67萬0.02%220億 USD0.09%US$319.79+0.24%
Simplify Health Care ETFPINK341.18萬1.07%3.19億 USD0.51%US$38.55+0.06%
First Trust Small Cap Growth AlphaDEX FundFYC328.79萬0.24%13.49億 USD0.70%US$114.94-0.37%
Vanguard Russell 2000 Growth ETFVTWG205.06萬0.12%17億 USD0.06%US$259.11-0.53%iShares Russell 2000 ETFIWMiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOT. Rowe Price Small-Mid Cap ETFTMSLVanguard Health Care ETFVHTSimplify Health Care ETFPINKFirst Trust Small Cap Growth AlphaDEX FundFYCVanguard Russell 2000 Growth ETFVTWGAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
